| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.5M | -16.7% |
| Cost of Revenue | $12.0M | -11.2% |
| Gross Profit | $41.5M | -18.2% |
| R&D Expense | $27.7M | +63.2% |
| SG&A Expense | $46.0M | +199.5% |
| Operating Income | -$79.1M | -147.0% |
| Pre-tax Income | -$82.6M | -119.6% |
| Income Tax | $264K | +84.6% |
| Net Income | -$82.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.0M | +395.0% |
| Accounts Receivable | $18.2M | -38.0% |
| Inventory | $6.2M | +59.7% |
| Current Assets | $64.8M | +49.4% |
| Total Assets | $71.7M | +39.6% |
| Current Liabilities | $65.4M | -13.8% |
| Long-term Debt | $3.1M | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.0M | -36.2% |
| Capital Expenditures | $1.6M | +3.6% |
| Investing Cash Flow | -$1.6M | -3.6% |
| Financing Cash Flow | $96.0M | +214.3% |
| Free Cash Flow | -$65.6M | -35.1% |
| -119.4% |
| EPS (Basic) | -$59.38 | -3832.5% |
| EPS (Diluted) | -$59.38 | -3832.5% |
| Total Liabilities |
| $143.0M |
| +70.9% |
| Stockholders' Equity | -$71.3M | +0.2% |